 |
| |
 |
Mussel adhesive protein (MAP) is a polyphenolic protein with non-toxic, biodegradable and low immunogenicity. These properties make MAP highly attractive for use in a variety of medical, biological and industrial applications. However, past commercial use of MAP has been greatly limited due to its low productivity, lack of functionality, and/or high production costs.
Kollodis BioSciences, Inc. has successfully addressed these issues by developing a proprietary recombinant protein expression system for large scale production of various mussel adhesive proteins derived from Mgfp-5, Mytilus galloprovincialis foot protein-5.
Kollodis BioSciences, Inc. (KBS) has successfully addressed these limiting use issues. Kollodis has developed a proprietary recombinant protein expression system for the large scale production of various mussel adhesive proteins derived from Mgfp-5, Mytilus galloprovincialis foot protein-5.
|
 |
Kollodis' proprietary MAP expression technology successfully addresses and resolves key manufacturing limitations.
|
 |
Kollodis BioSciences has successfully developed a unique, scaled-up manufacturing process for recombinant mussel adhesive protein (MAP) - a global first.
Quality control (QA/QC) is of prime importance to Kollodis. Kollodis operates an ISO 9001:2000 compliant fermentation manufacturing facility that operates with fully validated equipment and utilities that employ water for injection (WFI) and purified water tested to EP/USP standards. |
|
|
 |
